Comments
Talon future hinges on FDA chemotherapy decision
04.08.2012. | (Reuters) - Talon Therapeutics Inc, largely backed by venture capital, is banking on U.S. regulatory approval for its version of a nearly 50-year-old chemotherapy drug, which it expects will open the door to new licensing deals....
